Status
Conditions
Treatments
About
Primary Objective:
To evaluate objective response rate (ORR) in adult patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) who receive systemic treatment after at least 2 prior systemic therapies in the real-world setting according to Lugano classification of malignant lymphoma (Cheson, 2014) and as assessed by independent central review
Secondary Objectives:
To evaluate the following outcomes in adult patients with r/r DLBCL who are treated with currently available therapies in the real-world setting:
ORR according to Lugano classification and as assessed by treating physician evaluation
Complete Response (CR) rate according to Lugano classification and as assessed by:
Progression Free Survival (PFS) according to Lugano classification and as assessed by:
Overall Survival (OS)
Duration of response (DOR) according to Lugano classification and as assessed by
Disease control rate (DCR) according to Lugano classification and as assessed by:
Time to next treatment (TTNT)
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Note: Other protocol-defined Inclusion/Exclusion criteria apply
595 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal